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Objective: 1/ To evaluate if empirical antibiotic prescription on admission to our intensive care 
unit (ICU) respects the local recommendations for antibiotic prescription and to identify predic-
tors of nonadherence to these guidelines. 2/ To assess whether nonadherence to the guidelines 
is associated with increased in-hospital mortality due to the initial infection.
Materials and methods: This was a prospective six-month observational study performed 
in a 14-bed medical ICU. Patients were included if they received curative antibiotic therapy 
on admission. Respect of the local treatment recommendations was evaluated according to 
adherence to the local empirical guidelines defined in a 80-page booklet which is given in our 
hospital to every physician.
Results: Among 132 antibiotic prescriptions, 21 (16%) were unjustified (absence of infection), 
17 (13%) were microbiologically documented at admission, and nine (7%) were given for 
infections from unknown origin. Among the 85 (64%) empirical prescriptions that could 
be evaluated for adherence to local recommendations, nine (11%) were inappropriate and 
76 (89%) appropriate. In univariate analysis hospital-acquired infection was the sole predictor 
of inappropriate treatment (p = 0.0475). Independent predictors of in-hospital mortality due 
to the initial infection were inappropriate empirical treatment (odds ratio [OR] = 14.64, 95% 
confidence interval [CI]: 2.17–98.97; p = 0.006), prescription of fluoroquinolones (OR = 8.22, 
95% CI: 1.88–35.95; p = 0.005) and a higher Simplified Acute Physiology Score II score (per 
one-point increment (OR = 1.04, 95% CI: 1.01–1.07; p = 0.02).
Conclusion: Nonadherence to local empirical antibiotic therapy guidelines was associated 
with increased in-hospital mortality due to the initial infection.
Keywords:  antimicrobial therapy, appropriateness, mortality, intensive care unit
Introduction
It is widely accepted that prompt, appropriate antimicrobial chemotherapy is an important 
determinant of outcome in infected critically ill patients. The impact of treatment 
appropriateness on survival has been well documented during the course of ventilator-
associated pneumonia,1–4 bloodstream infections,5–7 sepsis, severe sepsis, and septic 
shock.8–11 Although the impact of treatment appropriateness has not been studied specifi-
cally in patients infected on admission to the intensive care unit (ICU), one might imagine 
that appropriate antimicrobial therapy is particularly warranted in this situation.
In all the above-mentioned studies,1–11 appropriateness of antibiotic therapy was 
only judged according to microbiological documentation. Undocumented infections Therapeutics and Clinical Risk Management 2009:5 492
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thus could not be evaluated. This represents an important 
limitation of the above-referenced studies, because 30% of 
hospital-acquired infections and 45% of community-acquired 
infections remain undocumented in ICUs.12 As our local 
anti-infective committee has established recommendations 
for empirical antibiotic therapy including clinically suspected 
microbiologically undocumented infections, we used them 
as a method of evaluating the appropriateness of empirical 
antibiotic prescriptions given for patients on admission to the 
ICU. Using this definition of treatment appropriateness, we 
characterized the quality of antibiotic treatment on admission, 
the factor(s) associated with treatment inappropriateness, 
and the impact of inappropriateness on in-hospital mortality 
attributed to the initial infection.
Materials and methods
setting and patients
This prospective study was carried out during a six-month 
period (February 12 to July 25, 2003) in the 14-bed medical 
ICU of Saint-Antoine Teaching Hospital in Paris, France. 
All patients receiving empirical curative antibiotic therapy 
in the first 24 hours following admission to the ICU were 
eligible. Empirical therapy was started after the collection of a 
minimum of two peripheral blood samples in 100% of cases, 
and of other clinically indicated microbiological samples in 
88% of cases (bronchoalveolar lavage fluid, pleural fluid, 
urine, cerebrospinal fluid, pus, etc.).
Data collection
The following data were systematically recorded: date and 
time of admission, age, gender, prior hospitalization in the 
previous year, origin of the patient, ongoing antimicrobial 
chemotherapy on admission and eventual modification of 
that treatment, Simplified Acute Physiology Score (SAPS II), 
ventilatory support, vasopressor administration, indication(s) 
for antimicrobial chemotherapy, community-acquired or 
hospital-acquired infection (classified as hospital-acquired 
if diagnosed more than 48 hours after hospital admission), 
antibiotics prescribed, time between admission and adminis-
tration of antibiotic therapy, and initiation of antibiotic therapy 
during the day time (between 8 am and 8 pm) or at night. After 
48 hours, we collected the microbiological data and recorded 
whether antimicrobial treatment was modified or not.
Justification and appropriateness 
of therapy
One week after ICU admission, all the files were reevaluated by 
two investigators (JLB and JT). This provided a classification 
of antibiotic treatments: 1/justified (presence of infection) or 
not (no infection); 2/prescribed for a correctly identified source 
of infection or not (site of infection not found or misdiagnosed 
site of infection); 3/appropriate or not (appropriateness being 
defined as respect of the published local recommendations for 
empirical antibiotic treatment. This could be done only for 
clinically, biologically and/or radiologically established but 
microbiologically undocumented infections). Appropriateness 
was evaluated by the investigators (JLB, JT) and concerned 
both the molecules employed and their dosages. Our pub-
lished local guidelines consist of an 80-page booklet updated 
every two years, which covers almost all infection sites. For 
example, concerning community-acquired broncho-pulmonary 
infections, the different presentations are defined (acute 
bronchitis, acute exacerbation of chronic obstructive pulmonary 
disease, acute pneumonia of the young adult [not severe 
or severe], acute pneumonia after aged 75 years [not severe 
or severe or with comorbidities] aspiration pneumonia) and, 
for each one, a first-line treatment is proposed (molecules and 
dosages) as well as some alternatives (two to four depending on 
the infection). This booklet is given personally to each clinician 
of our hospital. The recommendations present in this booklet 
are based on the practice guidelines of the Infectious Diseases 
Society of America and of the Société de Pathologie Infectieuse 
de Langue Française. Treatment was considered inappropriate 
when it did not respect these recommendations in terms of 
molecules and dosages, and when this resulted in a treatment 
inactive against the pathogens most frequently responsible for 
the type of infection presented by the patient.
Outcome
We recorded in-hospital mortality related to the infection 
present on ICU admission. This assessment was done inde-
pendently by the two main investigators; in the absence of 
consensus the chart was re-evaluated by the two investigators 
or by the entire medical staff of the ICU until a conclusion 
was drawn.
statistical analysis
The chi-squared test or Fisher’s exact test was used to 
compare qualitative variables, and the Mann–Whitney test 
was used for quantitative variables. Logistic regression 
models were used to identify risk factors for in-hospital 
mortality caused by the the initial infection. Characteristics 
with p values below 0.20 in univariate analysis were included 
in multivariate models based on a backward elimination 
procedure. All statistical tests were two-sided, with a type I 
error of 5%.Therapeutics and Clinical Risk Management 2009:5 493
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Results
During the study period, 374 patients were admitted to the 
ICU. One hundred twenty seven of them (34%) received 
curative antibiotic therapy within the first 24 hours. One 
hundred twenty two (96%) of these patients were treated for 
one focus of infection, and five patients for two foci (total 
132 prescriptions). The baseline characteristics of the patients 
are shown in Table 1. Patients who were given antibiotics on 
admission were older, had a higher SAPS II score, a longer 
ICU stay, and required a higher work load.
File review showed that 21 (16%) of the 132 prescriptions 
were unjustified because of absence of infection. The charac-
teristics of the 111 justified curative antibiotic prescriptions, 
which concerned 107 patients (four patients were treated for 
two infections) are shown in Table 2. Sixty-one (57%) of 
these 107 patients were outpatients, 39 (43%) were inpatients. 
45 of these 107 patients (42%) had already received antibi-
otics on admission. This antibiotic therapy was frequently 
modified on admission (31/45, 69%), in most cases (81%) 
because it was considered inappropriate by the prescriber. 
Antibiotic therapy begun on admission was always reviewed 
48 hours later and this led to treatment changes in 55% of 
the cases: narrowing (49%), escalation (6%). Most cases of 
treatment de-escalation were explained by the availability 
of microbiological data at 48 hours. Concerning treatment 
escalation, in most cases treatment was changed because on 
admission the nosocomial character of the infection had not 
been taken into account.
We first studied the appropriateness of the prescriptions 
according to our guidelines. Among the 111 justified pre-
scriptions, 17 (15%) were microbiologically documented 
at admission and nine (8%) with either no identification of 
the source of infection (eight cases) or a misdiagnosed site 
of infection (one case: intra-abdominal infection misdiag-
nosed as pneumonia). For these 26 cases, our local empirical 
treatment guidelines were not useful for the prescriber and 
thus we did not include them in the evaluation.
We thus determined the adherence to the guidelines of 
85 empirical antibiotic prescriptions for correctly diagnosed 
infections (77% of the 111 justified prescriptions): nine were 
classified as inappropriate (11%) and 76 appropriate (89%). 
All the nine inappropriate treatments were related to an inad-
equate choice of antimicrobial agent(s), but not to a wrong 
dosage. Univariate analysis (Table 3) showed that treatment of 
a hospital-acquired infection was the sole factor significantly 
associated with nonadherence to our local guidelines.
Thirty-nine of these 85 prescriptions (46%) were second-
arily documented following admission. Thus the total percent-
age of microbiologically documented infections at 48 hours 
was 50% (56/111, 17 on admission plus 39 secondarily).
Our last and main objective was to appreciate whether 
nonadherence to our local treatment guidelines was associated 
with in-hospital mortality due to the initial infection. Among 
the 26 in-hospital deaths (23% of the study population), the 
initial infection was considered to be the cause of death in 
13 cases (50%). Four factors were significantly associated 
with mortality due to the initial infection: 1/usage of intra-
venous epinephrine or norepinephrine; 2/empirical treatment 
inappropriate or prescribed for an infection of unknown 
origin; 3/usage of certain classes of antibiotics (fluoroquino-
lones and hospital-used beta-lactams); 4/high SAPS II score 
(Table 4). Mortality was much higher in case of inappropriate 
empirical treatment (44%, 4/9) and of empirical treatment 
without localization of the infection source (33%, 3/9) than 
in case of appropriate empirical treatment (5%, 4/73) and 
microbiologically documented treatment (12%, 2/16). There 
was a trend towards increased in-hospital mortality in case of 
modification of the antimicrobial chemotherapy given prior 
to admission, but this did not reach statistical significance 
(p = 0.13) (Table 4).
Table 1 Baseline characteristics of the patients admitted to the ICU during the study period classified in two groups: study patients 
who were given curative antibiotic therapy on admission and all other patients
Variablea Study patients (n = 127) Other patients (n = 247) p
Age (years) 60.8 ± 16.7 55.7 ± 19.0 0.01
Male to female ratio 1.50 1.44 ns
sAPs ii 41.9 ± 19.3 36.9 ± 22.4 0.01
Length of iCU stay (days) 8.6 ± 13.3 3.0 ± 4.3 0.01
Work load : Omega scoreb 126.8 ± 181 49.5 ± 71.2  0.01
iCU mortality 12.5% 11% ns
Notes:   aValues are expressed as mean ± sD, except for male to female ratio and iCU mortality; bThe Omega score is composed of therapeutic items accorded 1 to 10 points, 
and is divided into three categories as follows: Category 1, items entered only at the time of their first application; Category 2, items entered at each application; and Category 3, 
items entered every day of application. The total score, which covers the entire length of stay, is calculated by adding the points obtained in the three categories.
Abbreviation: SAPS II, simplified acute physiology score.Therapeutics and Clinical Risk Management 2009:5 494
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Multiple logistic regression analysis showed that 
inappropriate treatment, fluoroquinolone usage, and a higher 
SAPS II score were independently associated with in-hospital 
mortality from the initial infection (Table 4).
Discussion
It is now widely accepted that early and appropriate 
antimicrobial therapy of infections has an impact on in 
hospital mortality in the ICU setting. To our knowledge 
there is no published study whose specific aim was to 
evaluate antimicrobial therapy prescribed on admission to 
the ICU and to determine the impact of its appropriateness 
on hospital mortality. The link between treatment inap-
propriateness and mortality has been clearly established for 
certain types of infections: ventilator-associated pneumonia, 
bloodstream infections, or infections complicated by severe 
Table 2 Description of the justified curative antibiotic prescriptions administered on admission to the ICU (n = 111)
Aspect Data
number of treatment indications per patient One for 103 patients, two for 4 patients: 111 prescriptions
number of prescriptions for community-acquired infections 84 (76%)
number of prescriptions for nosocomial infections 27 (24%)
empirical treatment for correctly diagnosed infection 85 (77%)
empirical treatment for undiagnosed or misdiagnosed infection 9 (8%)
Microbiologically documented treatment 17 (15%)
number of monotherapies, bitherapies, and tritherapies Monotherapies: 41 (37%)
Bitherapies: 65 (58.5%)
Tritherapies: 5 (4.5%)
Classes of antibiotics prescribed, n = 180 Beta-lactams: 102 (57%)
  Co-amoxiclav: 67
  Cefotaxime or ceftriaxone: 14
    Tazocillin: 7
    Amoxicillin: 8
  Ceftazidime: 3
  Oxacillin: 2
  imipenem: 1
Macrolides or pristinamycin: 37 (20%)
  spiramycin: 35
  erythromycin: 1
  Pristinamycin: 1
Fluoroquinolones: 20 (11%)
  Ofloxacin: 14
  Ciprofloxacin: 6
Cotrimoxazole: 8 (4%)
Aminoglycosides: 6 (3.5%)
    Amikacin: 5
  gentamicin: 1
Nitro-imidazoles: 3 (2%)
Glycopeptides: 1 (0.5%)
Other classes: 3 (2%)
infection treated   Pneumonia: 58 (52%)
  Bronchitis: 21 (19%)
  intra-abdominal: 6 (5.5%)
  Urinary tract: 6 (5.5%)
  neuro-meningeal: 6 (5.5%)
    Various: 7 (6.25%)
  Unknown origin: 7 (6.25%)Therapeutics and Clinical Risk Management 2009:5 495
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sepsis or septic shock.1–12 In the case of ventilator-associated 
pneumonia, it has even been shown that modifying an ini-
tial inappropriate therapy according to the microbiological 
documentation obtained by bronchoalveolar lavage does 
not translate in a better outcome.3 Thus it appears that the 
efficacy of initial therapy, and notably of initial therapy on 
admission to the ICU is crucial for clinical outcome and is 
more important than adaptation of the treatment to micro-
biological results.
In the present work, we first assessed the different 
aspects of antibiotic prescription in the 24 hours following 
admission in our ICU. We found that 34% of the patients 
received antimicrobial treatment within this time period. 
But in fact 29% of the patients admitted were really infected 
at admission which is nonetheless almost one third of the 
patients. This result is similar to that reported (21%) in the 
international multicenter study from Alberti and colleagues.12 
This confirms that infection at admission to the ICU in an 
important issue. Another important point of our study is that 
85% of the treatments were empirically prescribed, only 
15% of the infections being microbiologically documented 
on admission. Similar results (14%) have been obtained 
in another study performed in one ICU.13 This stresses the 
importance of the appropriateness of initial empirical anti-
biotic therapy in the ICU setting.
To achieve that goal, one needs to be helped by local 
empirical treatment guidelines adapted to the susceptibility of 
the microorganisms and regularly reevaluated. In ventilator-
associated pneumonia, it has been shown that the application 
of an empirical treatment guideline can increase the initial 
administration of appropriate antimicrobial treatment.14 
In our hospital, local empirical prescription guidelines are 
available for almost all types of infections and we thus wanted 
to determine whether they were followed; if they were not, for 
Table 3 Univariate analysis of risk factors for inappropriate empirical antimicrobial therapy on admission (appreciated on 85 empirical 
prescriptions for correctly diagnosed infections; empirical prescriptions for misdiagnosed or undiagnosed infections (n = 9) and micro-
biologically documented prescriptions (n = 17) were excluded)
Factor Inappropriate therapy
(n = 9) No. (%)
Appropriate therapy
(n = 76) No. (%)
p value
sAPs ii score 45.8 ± 18.2 39.0± 18.7 0.22
sex (male) 8 (89) 45 (59) 0.14
Age 56 ± 12 58 ± 18 0.99
Mechanical ventilation 6 (67) 38 (50) 0.49
noninvasive ventilation 2 (22) 10 (13) 0.61
Dopamine use 0 (0) 3 (4) 1.00
epinephrine or norepinephrine use 3 (33) 9 (12) 0.11
Hospital-acquired infection 4 (44) 11 (14) 0.0475*
Delay between admission and treatment (in hours) 3.67 ± 2.45 4.30 ± 3.97 0.98
Treatment during the night 4 (44) 25 (33) 0.48
Ongoing antimicrobial treatment on admission:  no 6 (67) 51 (67) 0.74
  Yes and unchanged 0 (0) 7 (9)
  Yes and modified 3 (33) 18 (24)
Use of tazocillin, ceftazidim or imipenem 2 (22) 4 (5) 0.12
Other betalactam usage 7 (78) 67 (88) 0.33
Aminoglycoside usage 0 (0) 2 (3) 1.00
Fluoroquinolone usage 2 (22) 7 (9) 0.24
Macrolide or pristinamycin usage 6 (67) 29 (38) 0.15
Use of other antibiotics 2 (22) 8 (11) 0.29
Prior hospitalization in the preceding year 6 (67) 32 (43) 0.29
Patients receiving antibiotics before admission 2 (22) 34 (45) 0.29
Pneumonia or pleural fluid infection 7 (78) 44 (58) 0.30
Urinary tract infection 1 (11) 1 (1) 0.20
Other infection 1 (11) 31 (41) 0.14Therapeutics and Clinical Risk Management 2009:5 496
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which reasons; and if nonadherence to them had an impact 
on in-hospital mortality due to the initial infection.
Compared to the works that have already been performed 
and which were based on microbiological documentation, 
an advantage of our definition of treatment appropriateness 
is that it permits to evaluate the treatments of infections 
which remain undocumented, and this represented 50% 
of the cases in our study. This relatively high percentage 
could be explained by one main reason: 76% of the infec-
tions we investigated were community-acquired and Alberti 
Table 4 A Univariate analysis of risk factors for in-hospital mortality due to the initial infection (107 patients).  B) Risk factors independently 
associated with in-hospital mortality due to to the initial infection
Factor In-hospital mortality from the initial infection
Yes (n = 13) No.  (n = 94) p value
SAPS II score (mean ± SD) 58.7 ± 25.5 38.9 ± 18.0 0.005*
sex (male) 10 (77) 57 (61) 0.36
Age 66 ± 14 59 ± 17 0.14
Mechanical ventilation 8 (62) 46 (49) 0.56
noninvasive ventilation 2 (15) 8 (9) 0.35
Dopamine use 1 (8) 5 (5) 0.55
epinephrine or norepinephrine use 8 (62) 10 (11) 0.001*
hospital-acquired infection 6 (46) 19 (20) 0.07
Delay (hours) between admission and treatment 
(mean ± sD)
4.5 ± 2.6 4.5 ± 4.2 0.40
Treatment during the night 6 (46) 32 (30) 0.35
Ongoing antimicrobial treatment on admission: no 5 (38) 61 (65) 0.13
  Yes and unchanged 2 (15) 8 (9)
  Yes and modified 6 (46) 25 (27)
Use of tazocillin, ceftazidim or imipenem 4 (31) 6 (6) 0.02*
Use of other beta-lactams 10 (77) 80 (85) 0.43
Use of aminoglycosides 2 (15) 4 (4) 0.15
Use of fluoroquinolones 7 (54) 12 (13) 0.002*
Use of macrolides or pristinamycin 3 (23) 35 (37) 0.37
Use of other antibiotics 0 (0) 14 (15) 0.21
Prior hospitalization in the preceding year 8 (62) 43 (46) 0.38
Pneumonia of pleural fluid infection 5 (38) 55 (59) 0.16
Urinary tract infection 2 (15) 4 (4) 0.15
Other infection 4 (31) 34 (36) 0.77
Bacteremia 3 (23) 8 (9) 0.13
Microbiological documentation at 48 hours 7 (54) 40 (43) 0.42
  Origin of the patient: emergency unit 3 (23) 45 (48) 0.17
  Other unit of the hospital 8 (62) 33 (35)
  Community 2 (15) 16 (17)
Appropriate or excessive empirical treatment 4 (31) 69 (73) 0.002*
  inappropriate empirical treatment 4 (31) 5 (5)
    empirical treatment without localization 
of the infection source
3 (23) 6 (6)
  Microbiologically documented treatment 2 (15) 14 (15)
B)
Risk factor OR (95% CI) p value  
inappropriate treatment 14.64 (2.17–98.97) 0.006
Use of fluoroquinolones 8.22 (1.88–35.95) 0.005
increasing sAPs ii score (one-point increments) 1.04 (1.01–1.07) 0.02
Abbreviations: CI, confidence interval; OR, odds ratio; SAPS II, simplified acute physiology score; SD, standard deviation.Therapeutics and Clinical Risk Management 2009:5 497
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and colleagues clearly showed that the documentation rates 
are lower for community-acquired infections compared 
to hospital-acquired or ICU-acquired infections.12 In their 
international prospective cohort study of 3034 infectious epi-
sodes, the documentation rates were 86%, 71%, and 55% for 
ICU-acquired, hospital-acquired, and community-acquired 
infections, respectively. Furthermore, the nonevaluation of 
undocumented infections could represent a bias, because 
infections due to microorganisms difficult to identify are 
therefore for the most part not taken into account in the 
evaluation. On the other hand, with our definition of treatment 
appropriateness infections microbiologically documented on 
admission could not be evaluated. But they represented only 
a small percentage of the cases included (15%). Furthermore, 
it is clear that the risk of inappropriate treatment is lower 
when microbiological documentation is available.
We found that 89% of the initial empirical prescriptions 
were appropriate. The percentages of appropriateness found 
by other workers are similar to ours (from 83% to 99%) in 
some studies8,11,13 and lower (70% to 77%) in others.6,9,15 
However, our results are difficult to compare with those of 
other works because, in all these studies appropriateness was 
judged according to microbiological documentation.
We then wanted to assess which factors were associated 
with treatment inappropriateness and whether our definition 
of treatment inappropriateness based on treatment guidelines 
had an impact on in-hospital mortality due to the initial 
infection. By univariate analysis, the only factor associated 
with empirical inappropriate prescriptions was the hospital-
acquired characteristics of the infection treated. Examination 
of the cases showed that the main cause for this association 
was that the hospital-acquired character of the infection 
was not taken into account in the initial prescription, and 
antibiotic-resistant hospital-acquired organisms were there-
fore not covered by the prescription.
Concerning the link with mortality due to the initial 
infection, we found by multivariate analysis that the risk of 
in-hospital mortality from the initial infection was more than 
14 times higher in case of inappropriate empirical treatment. 
However, our work suffers from some limitations: first, it is 
a monocentric study; second the number of cases evaluated 
was relatively low leading to large confidence intervals; 
third, the way appropriateness was judged depended on our 
local prescription guidelines and cannot be generalized to 
other hospitals.
As regards to the types of infections included, the study 
performed by Kollef and colleagues15 is the only one that can 
be compared with our work. They performed a prospective 
cohort monocentric study to evaluate the relationship 
between inappropriate antimicrobial treatment of infections 
(all infections included) and hospital mortality. By multivari-
ate analysis they also found that inappropriate antimicrobial 
treatment was the most important independent determinant 
of hospital mortality (adjusted OR 4.27, 95% CI: 3.35–5.44; 
p  0.001). However, two major differences exist between 
the two studies: First, Kollef and colleagues did not restrict 
their study to patients already infected on admission but also 
included ICU-acquired infections. Second, their definition of 
treatment inappropriateness was the classical one used in all 
studies so far performed: prescription of at least one antibiotic 
active against the microorganism(s) isolated.
The other independent risk factor for hospital mortal-
ity that we identified was prescription of fluoroquinolones. 
Nseir and colleagues showed that fluoroquinolone use was 
an independent risk factor for subsequent acquisition of mul-
tidrug resistant bacteria in the ICU by the patient.16 We did 
not observe this phenomenon among the seven patients who 
received fluoroquinolones and who died. But we observed 
that four of them were treated for hospital-acquired infections 
and in three of them treatment was inappropriate because the 
hospital-acquired character of the infection was not taken into 
account. Thus, fluoroquinolone-resistant organisms could 
have been implicated; but unfortunately these cases were not 
microbiologically documented. Concerning the three remain-
ing patients treated with fluoroquinolones for community-
acquired infections and then died, we found a link between 
the prescription and death for one patient: he presented with 
acute prostatitis and was treated empirically with cefotaxime 
and ofloxacin. This infection was secondarily microbiologi-
cally documented with a strain of Enterocococcus faecalis 
being isolated from blood and urine. It is well known that this 
species is resistant to both third-generation cephalosporins 
and fluoroquinolones. Fluoroquinolone prescription was 
not implicated in the death of the two other patients. They 
presented with bacteremia due to fluoroquinolone-susceptible 
Staphylococcus aureus and their death was attributable to the 
severity of the sepsis in both cases.
Our work also showed that infections of undetermined 
origin are not rare and carry a high mortality rate. This had 
already been observed in other studies which dealt with ICU 
patients suffering from severe infections: sepsis or septic 
shock.8,17 One likely explanation is that, when treating an 
occult infectious process, most physicians are reluctant to 
prescribe potent broad-spectrum agents immediately. This 
emphasizes the need for an aggressive search for a focus of 
infection in all infected patients admitted to the ICU.Therapeutics and Clinical Risk Management 2009:5
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This study is thus the first to show that nonadherence to 
local empirical antibiotic prescription guidelines for patients 
infected on ICU admission is independently associated with 
increased in-hospital mortality due to the initial infection. 
More studies are needed to confirm our findings.
Disclosure
The authors report no conflicts of interest in this work.
References
  1.  Iregui M, Ward S, Sherman G, et al. Clinical importance of delays in the 
inititiation of appropriate antibiotic treatment for ventilator-associated 
pneumonia. Chest. 2002;122:262–268.
  2.  Kollef MH, Ward S. The influence of mini-BAL cultures on patient 
outcomes: implications for the antibiotic management of ventilator-
associated pneumonia. Chest. 1998;113:412–420.
  3.  Luna CM, Vujacich P, Niedermann MS, et al. Impact of BAL data on 
the therapy and outcome of ventilator-associated pneumonia. Chest. 
1997;111:676–685.
  4.  Rello J, Gallego M, Mariscal D, et al. The value of routine microbial 
investigation in ventilator-associated pneumonia. Am J Respir Crit Care 
Med. 1997;156:196–200.
  5.  Bryan CS, Reynolds KL, Brenner ER. Analysis of 1186 episodes of 
Gram-negative bacteremia in non-university hospitals: the effects of 
antimicrobial therapy. Rev Infect Dis. 1983;5:629–638.
  6.  Ibrahim EH, Sherman G, Ward S, et al. The influence of inadequate 
antimicrobial treatment of bloodstream infections on patient outcomes 
in the ICU setting. Chest. 2000;118:146–155.
  7.  Lodise TP, McKinnon PS, Swiderski L, et al. Outcomes analysis of 
delayed antibiotic treatment for hospital-acquired Staphylococcus 
aureus bacteremia. Clin Infect Dis. 2003;36:1418–1423.
  8.  Garnacho-Montero J, Garcia-Garmendia JL, Barrero-Almodovar A, 
et al. Impact of adequate empirical antibiotic therapy on the outcome 
of patients admitted to the intensive care unit with sepsis. Crit Care 
Med. 2003;31:2742–2751.
  9.  Harbarth S, Garbino J, Pugin J, et al. Inappropriate initial antimicrobial 
therapy and its effect on survival in a clinical trial of immunomodulating 
therapy for severe sepsis. Am J Med. 2003;115:529–535.
10.  Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before 
initiation of effective antimicrobial therapy is the critical determinant of 
survival in human septic shock. Crit Care Med. 2006;34:1589–1596.
11.  Leone M, Bourgoin A, Cambon S, et al. Empirical antimicrobial therapy 
of septic shock patients: adequacy and impact on the outcome. Crit 
Care Med. 2003;21:462–467.
12.  Alberti C, Brun-Buisson C, Burchardi H, et al. Epidemiology of sepsis 
and infection in ICU patients from an international multicentre cohort 
study. Intensive Care Med. 2002;28:108–121.
13.  Montay V, Alfandari S, Senneville B, et al. Evaluation de la prescrip-
tion antibiotique dans un service de réanimation polyvalente. Presse 
Médicale. 1998;27:700–704.
14.  Ibrahim EH, Ward S, Sherman G, et al. Experience with a clinical 
guideline for the treatment of ventilator-associated pneumonia. Crit 
Care Med. 2001;29:1109–1115.
15.  Kollef MH, Sherman G, Ward S, et al. Inadequate antimicrobial treat-
ment of infections: a risk factor for hospital mortality among critically 
ill patients. Chest. 1999;115:462–474.
16.  Nseir S, Di Pompeo C, Soubrier S, et al. First-generation fluoroquino-
lone use and subsequent emergence of multidrug-resistant bacteria in 
the intensive care unit. Crit Care Med. 2005;33:289–289.
17.  Reyes WJ, Brimioulle S, Vincent JL. Septic shock without documented 
infection: an uncommon entity with a high mortality. Intensive Care 
Med. 1999;25:1267–1270.